NorstellaLinQ: From pipeline to patient with comprehensive data

Run time

56 seconds

NorstellaLinQ unites several previously strong organizations and their robust product portfolios to create what is described as the industry’s most complete and comprehensive data asset spanning from pipeline to patients. This integrated asset enables holistic, end-to-end visibility across therapy areas, including market access, coverage, and real-world data on patients receiving a therapy, as well as the barriers to initiating and maintaining treatment.

View video transcript

NorstellaLinQ is really an exciting proof point for why as Norstella we brought some fantastic organizations together that were already in their own right, very strong organizations with very strong product portfolios. What you have now is the industry’s most complete and comprehensive data asset from pipeline to patients. What does that look like across that therapy area in terms of market access and coverage to ultimately what is reflected in the real-world data around patients that are on that therapy, the barriers to getting them on that therapy, really in a holistic way, being able to see that picture end to end.

Frequently asked questions

What makes NorstellaLinQ unique?
NorstellaLinQ combines multiple industry-leading data assets and solutions into a single connected platform, delivering a more complete and end-to-end understanding of healthcare markets and patient journeys.
What does “pipeline to patients” mean?
“Pipeline to patients” refers to connecting insights across the full lifecycle of a therapy—from drug development and clinical research to market access, coverage, and real-world patient outcomes.
What types of insights does NorstellaLinQ provide?
The platform provides insights into market access, payer coverage, patient treatment journeys, therapy adoption, access barriers, and real-world outcomes.
How does real-world data fit into NorstellaLinQ?
Real-world data helps organizations understand how therapies perform in clinical practice, including patient experiences, treatment patterns, and challenges accessing care.

Real-world data in 2025 and beyond: Closing the strategy gap